Literature DB >> 3130041

Adenosine deaminase and purine phosphorylase activities in lymphocytes and red blood cells of patients with carcinoma of the larynx.

T Gierek1, M Drózdz, J Pilch, A Jendryczko, J Piekarska.   

Abstract

Lymphocytes from patients with cancer of the larynx have been characterized by the activity of two enzymes involved in purine metabolism--adenosine deaminase and purine nucleoside phosphorylase. It has been shown that purine nucleoside phosphorylase activity was 1.5-fold higher in lymphocytes of patients in comparison with a group of healthy individuals. Adenosine deaminase activity in lymphocytes was elevated three to four-fold. The authors suggest that especially the estimation of adenosine deaminase activity in lymphocytes would be a useful laboratory test in the study of immune responsiveness of patients with cancer of the larynx.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3130041     DOI: 10.1016/s0385-8146(87)80027-5

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  4 in total

1.  Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue.

Authors:  Balwant Rai; Jasdeep Kaur; Reinhilde Jacobs; Suresh Chander Anand
Journal:  Clin Oral Investig       Date:  2010-04-09       Impact factor: 3.573

2.  Serum adenosine deaminase activity in brain tumours.

Authors:  S Manjula; A Raja; S N Rao; A R Aroor; A Rao
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  A Label-Free Fluorescent Assay for the Rapid and Sensitive Detection of Adenosine Deaminase Activity and Inhibition.

Authors:  Xinxing Tang; Kefeng Wu; Han Zhao; Mingjian Chen; Changbei Ma
Journal:  Sensors (Basel)       Date:  2018-07-27       Impact factor: 3.576

4.  Serum adenosine deaminase activity in cutaneous anthrax.

Authors:  Mahmut Sunnetcioglu; Sevdegul Karadas; Mehmet Aslan; Mehmet Resat Ceylan; Halit Demir; Mehmet Resit Oncu; Mustafa Kasım Karahocagil; Aysel Sunnetcioglu; Cenk Aypak
Journal:  Med Sci Monit       Date:  2014-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.